J2T-DM-KGAE - ClinicalTrials.gov - NCT04250350
J2T-DM-KGAE - ClinicalTrials.gov - NCT04250350
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have atopic dermatitis that has been present for at least one year
Participants must have had an inadequate response to topical medications (medications applied to the skin)
Participants must NOT
Participants must not have received a vaccine within 12 weeks of starting the study
Participants must not have hepatitis
Participants must not have a history of HIV
Participants must not have a history of cancer within 5 years
Women must not be pregnant, breastfeeding or plan to become pregnant during the study
Trial Summary
Conditions the trial is for
Pediatric Atopic Dermatitis (Eczema)
What the trial is testing?
Lebrikizumab
Could I receive a Placebo?
no
Enrollment Goal
200
Trial Dates
February 2020 - May 2022
Trial Phase
3
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have atopic dermatitis that has been present for at least one year
Participants must have had an inadequate response to topical medications (medications applied to the skin)
Participants must NOT
Participants must not have received a vaccine within 12 weeks of starting the study
Participants must not have hepatitis
Participants must not have a history of HIV
Participants must not have a history of cancer within 5 years
Women must not be pregnant, breastfeeding or plan to become pregnant during the study
Trial Summary
Conditions the trial is for
Pediatric Atopic Dermatitis (Eczema)
What the trial is testing?
Lebrikizumab
Could I receive a Placebo?
no
Enrollment Goal
200
Trial Dates
February 2020 - May 2022
Trial Phase
3
Trial Locations
Hide locations not currently recruiting